Expertise in
7
conditions

Gilles Capellier

Ajaccio, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
7
conditions
Ajaccio, FR 

Overview

Gilles Capellier practices practicing medicine in Ajaccio, France.

Mr. Capellier is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Respiratory Acidosis, Pulmonary Embolism, Acute Respiratory Distress Syndrome (ARDS), Embolectomy, and Liver Transplant.

He is actively involved in clinical research, co-authoring 105 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Ajaccio, 20090, France
Other Locations
Besancon, France
Dijon, France
Nancy, France
Equipe Avenir 3830, Chartres, Fort De France, Angers, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
Enrollment Status: Recruiting
Publish Date: August 05, 2025
Intervention Type: Drug
Study Drug: Levosimendan
Study Phase: Phase 3
Impact on Mortality of the Timing of Renal Replacement Therapy in Patients With Severe Acute Kidney Injury in Septic Shock: the IDEAL-ICU Study (Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit): Study Protocol for a Randomized Controlled Trial
Impact on Mortality of the Timing of Renal Replacement Therapy in Patients With Severe Acute Kidney Injury in Septic Shock: the IDEAL-ICU Study (Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit): Study Protocol for a Randomized Controlled Trial
Enrollment Status: Terminated
Publish Date: February 09, 2026
Intervention Type: Procedure
Study Phase: Phase 3
An International Survey on Aminoglycoside Practices in Critically Ill Patients: AMINO III Survey
An International Survey on Aminoglycoside Practices in Critically Ill Patients: AMINO III Survey
Enrollment Status: Completed
Publish Date: November 21, 2025
Intervention Type: Other
Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock: A Multicenter, Stepped Wedge Cluster Randomized Trial
Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock: A Multicenter, Stepped Wedge Cluster Randomized Trial
Enrollment Status: Completed
Publish Date: September 19, 2025
Intervention Type: Other
Study Phase: Not Applicable
TAME Cardiac Arrest Trial: Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest: A Phase III Multi-Centre Randomised Controlled Trial
TAME Cardiac Arrest Trial: Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest: A Phase III Multi-Centre Randomised Controlled Trial
Enrollment Status: Unknown
Publish Date: April 20, 2022
Intervention Type: Other
Study Phase: Not Applicable
Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain Death
Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain Death
Enrollment Status: Completed
Publish Date: October 24, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events
Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events
Enrollment Status: Completed
Publish Date: July 18, 2018
Intervention Type: Genetic, Other
Study Phase: Not Applicable
View 6 Less Clinical Trials

105 Total Publications

The authors reply.
The authors reply.
Journal: Critical care medicine
Published: February 03, 2026

Frequently Asked Questions about Gilles Capellier

Is Gilles Capellier a top-rated expert for Respiratory Acidosis?

MediFind is an objective health platform that identifies experts based on real-world data. Gilles Capellier is classified as an Distinguished expert for Respiratory Acidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gilles Capellier participate in research or clinical trials?

Yes. Gilles Capellier has published 105 articles and abstracts on conditions like Respiratory Acidosis. You can view a list of Gilles Capellier's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Capellier's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile